Question

There is a race among scientist to find a treatment option and a vaccine for COVID-19. Using your understanding of experimental research designs explain why a treatment option and a vaccine will take time to develop

Answer 1

Experimental study design for COVID 19 infected persons as a group or various dependent groups observed with broad spectrum antiviral treatment. this disease needs safe and effective treatment. Remdesivir is an antiviral medicine for treating virul infection disease, expieimntal study design included the participants with various conditions with cold symptoms in the study. antiviral drug treatment is given for them up to 10days total, and observation is done through physical exam and continuous monitoring, but participants did not have solid data for improved clinical outcome and shows some participants died and increased mortality rate with severe clinical features and some patients restricted with symptoms relieve, so study design need multiple endpoints in the current knowledge. a clinical trial being planned by scientist for safe and effective treatment outcomes with the standard of care worldwide. developing new vaccines against COVID 10 and treatment options for positive outcomes it takes time through clinical trials and randomized study.